Vickers AJ, Fine S, ProQuant Group
Eur. Urol. 89 (4) 298-301 [2026-04-00; online 2025-12-18]
We describe the rationale for using quantification of Gleason pattern 4 rather than the proportion of Gleason patterns for risk stratification in prostate cancer, as proposed by the ProQuant Group. We outline research that will be conducted to assess this strategy, and invite individuals interested in collaboration to join the group.
PubMed 41419390
DOI 10.1016/j.eururo.2025.11.013
Crossref 10.1016/j.eururo.2025.11.013
pii: S0302-2838(25)04835-3